Related Experiment Video
Updated: Jul 19, 2026
10:29
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
CD30+, large T-cell lymphoma: diagnostic distinction and management
Eric C Parlette1, Camille A Tabor
1Uniformed Services University of Health Sciences, Department of Dermatology, US Naval Hospital, Okinawa, Japan. ecparlette@yahoo.com
Dermatology Online Journal
|November 7, 2006
Summary
Cutaneous T-cell lymphoma (CTCL) presents variably. Primary cutaneous, CD-30+, anaplastic, large T-cell lymphoma is an indolent CTCL subtype that often resolves on its own.
Area of Science:
- Dermatology
- Oncology
- Immunology
Background:
- Cutaneous T-cell lymphoma (CTCL) encompasses a diverse range of conditions.
- Accurate diagnosis relies on histologic and immunophenotypic analysis.
- Diagnosis guides prognosis and treatment strategies.
Observation:
- Primary cutaneous, CD-30+, anaplastic, large T-cell lymphoma is a specific subtype of CTCL.
- This subtype is characterized by its indolent nature.
- Spontaneous regression is a common feature.
Findings:
- Histologic and immunophenotypic confirmation are crucial for precise CTCL diagnosis.
- Categorization of CTCL influences patient outcomes and therapeutic approaches.
- Primary cutaneous, CD-30+, anaplastic, large T-cell lymphoma demonstrates indolent behavior.
Implications:
- Understanding CTCL subtypes like primary cutaneous, CD-30+, anaplastic, large T-cell lymphoma improves patient management.
- Accurate diagnosis leads to tailored therapeutic algorithms.
- The indolent and self-resolving nature of this subtype suggests less aggressive treatment may be appropriate.
